| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Smooth Muscle Research Group and Canadian Institutes of Health Research (CIHR) Group in Regulation of Vascular Contractility, University of Calgary, Alberta, Canada. Present address for O.C.-C. is Hoffmann-La-Roche Ltd, Preclinical Research, Basel, Switzerland; for K.I., the Department of Pharmacology, Yamagata University School of Medicine, Yamagata, Japan; and for D.P.S., the Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Correspondence to Dr William C. Cole, Smooth Muscle Research Group, Faculty of Medicine, University of Calgary, 3330 Hospital Dr, NW, Calgary, Alberta, Canada T2N 4N1. E-mail wcole{at}ucalgary.ca
| Abstract |
|---|
|
|
|---|
Key Words: vascular smooth muscle 4-aminopyridine Kv1.5 Kv1.2 voltage-gated K+ channel
| Introduction |
|---|
|
|
|---|
The molecular identity of KDR of VSM remains to be defined, but transcripts encoding several 4-AP-sensitive Kv1 channel subunits, for example Kv1.2 and Kv1.5, are expressed in VSM (eg, Roberds and Tamkun,5 Overturf et al,6 and Yuan et al7) including myocytes of RPV (Clément-Chomienne et al8 and see also Thorneloe et al9 in this issue of Circulation Research). Binding of 4-AP by Kv occurs from the intracellular face of the membrane, and when applied to the exterior of cells, it must first cross the cell membrane in its non-ionized form.1012 Previous studies show considerable variability in the state-dependence of 4-AP block, eg, during or after activation (open-state block), closed (resting)-state block, or block after inactivation.1216 Identification of the mechanism(s) of 4-AP block has been advanced through the study of recombinant Kv channels. For example, analyses of the effects of 4-AP on Shaker family Kv1 channels, including Kv1.2, Kv1.4 and Kv1.5,14,1620 as well as Kv2.1 and Kv3.1,12 indicate that 4-AP binds to these channels in the open state and remains bound (or trapped) after channel closure. In light of the expression in VSM of Kv1 subunits that exhibit open-state block by 4-AP, it would be expected that a similar mechanism should be involved if these subunits contribute to the native channels; however, KDR of coronary arterial myocytes were concluded to be suppressed by a closed-state blocking mechanism.21
The objectives of this study were 3-fold: (1) to determine the state-dependence of inhibition by 4-AP of RPV KDR; (2) to test the hypothesis that the features of 4-AP block of the native KDR are identical to those of Kv1.5 and Kv1.2, which are the only delayed rectifier-type Kv1 subunits expressed in this vessel (see Thorneloe et al9); and (3) to assess the relative contribution of homo- and heteromultimeric Kv1.2 and Kv1.5 channels to native KDR current of RPV. RPV KDR were found to be inhibited by 4-AP while in the open state, but the drug remains trapped in the pore during channel closure. A feature of 4-AP block of KDR was identified that was not mimicked by homotetrameric Kv1.5 channels, but was apparent in recordings of Kv1.2 currents, as well as currents due to heteromultimeric association of Kv1.2 and Kv1.5. Finally, native KDR current was found to be insensitive to charybdotoxin-block of homomultimeric Kv1.2 channels. The findings of this study provide novel insight into the mechanism of inhibition by 4-AP as well as the molecular identity of vascular KDR channels.
| Materials and Methods |
|---|
|
|
|---|
Transfection and Tandem Construct
RPV Kv1.5 (AF056943) and Kv1.2 (AF284420) cDNAs in pcDNA3 were transfected individually, or in combination, into human embryonic kidney 293 (HEK) cells (American Type Culture Collection) along with cDNA encoding green fluorescent protein (GFP).8 A tandem construct of Kv1.5-Kv1.2 was engineered by adding a linker sequence encoding seven glycines between the 3' end of Kv1.5 and 5' end of Kv1.2 and expressed in HEK cells.
Electrophysiological Measurements
Whole-cell currents were recorded ±4-AP (Sigma Chemical) or ± charybdotoxin (Alomone Laboratories) by whole-cell patch clamp23 and analyzed as previously described.8,22 RPV KDR open probability ±4-AP in cell-attached (C-A) patches was determined from amplitude histograms (bin width 0.1 pA) based on identical duration recording periods of 75 to 100 seconds.24 Analysis of open dwell time using pClamp software (Axon Instruments) was based on >200 transitions ±4-AP from 7 C-A patches. Partial transitions of >50% of the unitary amplitude during bursts were considered to be closures. The C-A patch bath and pipette solutions respectively contained (in mmol/L): KCl 140, MgCl2 2.3, glucose 10, EGTA 1, and (N-[hydroxyethyl) piperazine-N'-[2-ethanesulfonic acid] (HEPES) 10 (pH 7.4) and KCl 5.4, NaCl 140, CaCl2 1, MgCl2 1, glucose 5.5, and HEPES 10 (pH 7.4; iberiotoxin (200 nmol/L; Alomone Laboratories) was added to block BKCa activity). Data were compared by paired Students t test or repeated measures ANOVA followed by Dunnetts post hoc test. A level of P<0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
3.25 minutes with a 15-second interpulse interval, but the 4-AP-sensitive current had only declined by 50% and 25% at this time when the interval was 30 and 90 seconds, respectively (Figure 1B). Additionally, fewer pulses were required to achieve steady-state block when the 4-AP concentration was increased: the inhibition was stable after 22±1.2, 11.4±0.5, and 9.4±1.4 pulses for 0.1, 1, and 10 mmol/L 4-AP, respectively (15-second interpulse interval; n>3 for each concentration).
|
|
To assess the extent of closed-state block, cells were treated with 4-AP (0.2 or 1 mmol/L) for 5 to 10 minutes at -60 mV prior to the first depolarizing step. Figure 2 shows that a pulse-dependent decline in current amplitude was observed regardless of the length of time of 4-AP (1 mmol/L) treatment and that the initial activation of current during the first depolarizing step in 4-AP was not affected. If the drug interacted with closed KDR, an immediate stable level of inhibition would have been expected. Also, an increased rate of decay in current amplitude was evident during the first pulse in 4-AP (note the arrow in Figure 2A), consistent with a development of channel block during the pulse. This decay occurred with time constants of 136.1±9.7 and 88.2±9.8 ms in 0.2 and 1 mmol/L 4-AP, respectively (n=4 and 7).
Figure 3 shows representative families of whole-cell KDR currents, as well as average data for comparison of the I-V relationship for end-pulse current and steady-state activation based on analysis of normalized tail current amplitude versus voltage ±1 mmol/L 4-AP. 4-AP reduced end-pulse current at all potentials positive to -40 mV and caused a shift of +18.8±1.4 mV in the voltage of half-maximal activation (V0.5), as described for KDR of rabbit coronary arterial myocytes.21 A similar but smaller shift in V0.5 was observed for 0.2 mmol/L 4-AP of +11.0 mV from -14.6±1.2 to -3.6±1.4 mV (n=4; P<0.05).
|
The concentration-dependence of KDR inhibition by 4-AP was determined. End-pulse current amplitude at +20 mV was reduced to a maximum that was
30% of that in control conditions, indicating the presence of 4-AP-sensitive and -resistant outward currents in RPV.22 The concentration required for half-maximal inhibition at +20 mV using the protocols of Figures 1 and 2 were identical at 213±65 and 180±32 µmol/L and not different from the values obtained for RPV Kv1.5 (180±32 and 190±43 µmol/L) (P>0.05; see online Figure 1 in the online data supplement available at http://www.circresaha.org), but different from the value of 74 µmol/L reported for Kv1.2.14
Effect of 4-AP on Mean Open Time of Single RPV KDR
4-AP-sensitive RPV KDR current is due to channels with a conductance of approximately 10 pS in asymmetrical (5.4/140 mmol/L) KCl recording conditions.8,24 The effect of 4-AP (0.2 mmol/L) on mean open time of these channels was assessed using C-A patches held at -10 and +30 mV. Patches exhibiting only one channel are rarely obtained,24 so 4 of the 7 patches analyzed in this study contained multiple channels (bursts involving multiple openings were ignored). Identical effects of 4-AP on mean open time were observed during repeated 500-ms step depolarizations and when the patches were held at a constant voltage, thus the data from these 2 protocols were combined in the analysis. Figure 4 shows representative traces and values for open probability from a single patch, as well as average values of mean open time in 7 patches at -10 and +30 mV ±4-AP. Unitary current amplitude was not affected (Figure 4A), as previously reported,8,24,25 but the change in mean open time in 4-AP was less at +30 compared with -10 mV. In the presence of 4-AP, mean open time was 0.41 of the control value at -10 mV, but it was 0.66 of the control value at +30 mV (Figure 4B). These data confirmed the involvement of an open state interaction of 4-AP with KDR and indicate that the association of drug to its binding site on the channel was voltage-dependent.
|
Lack of Effect of Voltage on 4-AP Dissociation From RPV KDR
Preliminary experiments showed that washout of 4-AP inhibition of KDR required 10 to 15 minutes (ie, 40 to 60 steps at 0.66 Hz; data not shown). A 20-minute period for washout of 4-AP was therefore considered to be sufficient for the intracellular 4-AP concentration to decline to a level that would not affect the channels. To evaluate the voltage dependence of relief of block from a trapped state, cells were treated with 4-AP to achieve stable block and then held at -60 mV during 20 minutes of superfusion with control solution before the application of test pulses to 0 mV or +20 mV. The initial activation of KDR during the first pulse to 0 mV and +20 mV was similar to that recorded in the presence of 4-AP (Figure 5). However, a slow increase in current during the pulse occurred at both voltages. The rate of reblock by 4-AP should be insignificant due to the very low concentration of the drug in the intracellular compartment. Therefore, this slow increase in current is a reasonable representation of the dissociation of 4-AP from the channels. Significantly, there was no difference in time constant for the slow component of increase in current at 0 mV and +20 mV: 170.7±23.3 ms (n=10) and 211.0±57.7 ms (n=12), respectively (P>0.05). Moreover, a similar value was obtained for relief of 4-AP block of RPV Kv1.5 at +20 mV (150.3±33.8 ms; n=3). These data indicate that 4-AP dissociation from the channels is not affected by membrane voltage.
|
Effect of 4-AP on Cloned Kv of RPV
The state-dependence of 4-AP inhibition of Kv1.2 and Kv1.5 channels was studied previously,14,1820 but the effect of 4-AP on the voltage dependence of activation was not reported. A pulse-dependent decline in current amplitude and increased rate of current decay during depolarizing steps was observed for homotetrameric Kv1.5 or Kv1.2 channels (Figures 6A and 6B). Identical results were obtained when these subunits were coexpressed (Figure 6C); the coimmunoprecipitation experiments in Thorneloe et al9 illustrate the association of Kv1.2 and Kv1.5 following coexpression in HEK293 cells.9 However, the subunit composition of the channels is not known for certain in coexpression experiments: mixtures of homomultimeric and heteromultimeric channels with varied numbers of Kv1.2 and Kv1.5 subunits are possible. For this reason, the effect of 4-AP on a tandem construct in which the 2 subunits were linked by a seven glycine repeat sequence, and thereby, heterotetrameric channels with a known 1:1 ratio of Kv1.2 to Kv1.5 subunits was assessed. The tandem construct also exhibited evidence of a pulse-dependent decline in current amplitude (Figure 6D).
|
The effect of 4-AP on steady-state activation was determined from families of whole-cell currents due to Kv1.5, Kv1.2, coexpression of these subunits, and the tandem construct. Figure 7 shows that the effect of 4-AP (1 mmol/L) on the voltage dependence of activation of these currents was different. Significantly, the voltage dependence of activation of currents due to Kv1.5 channels was not affected by 4-AP (Figure 7A). For comparative purposes, we also studied Kv1.5 expressed in mouse L cells, in which Kv1.5 coassembles with an endogenous Kvß2.1 subunit,26 but an identical lack of change in activation was observed (-15.3±0.5 to -18±1.2 mV; n=3, P>0.05). In contrast, a shift in activation of +22.8±4.1 mV was observed for currents due to homotetrameric Kv1.2 channels in the presence of 4-AP (Figure 7B). Figures 7C and 7D indicate that the shift in activation of Kv1.2 was also evident when this subunit was coexpressed with Kv1.5 to produce heteromultimeric channels: average values were +15.7±5.6 and +12.2±1.0 mV for the coexpression and tandem experiments, respectively. Note that the activation of current due to coexpression of Kv1.2 and Kv1.5 mimics that of Kv1.5, but the tandem activated over a considerably more negative voltage range. The reason for this is not evident; it is possible that the linkage of the subunits with the polyglycine sequence may enhance the mobility of the voltage sensors of the tandem channels.
|
Lack of Effect of Charybdotoxin on RPV KDR
Charybdotoxin was previously shown to block homomultimeric Kv1.2 channels2729 but not heteromultimeric channels due to coexpression of Kv1.2 with Kv1.5.29 Figure 8 shows that charybdotoxin (50 nmol/L) failed to affect the amplitude of KDR currents in the presence of iberiotoxin (100 nmol/L). The latter was used to eliminate any residual contamination of the native current recordings by charybdotoxin-sensitive BKCa channels not suppressed by the 10 mmol/L BAPTA-containing pipette solution used in the experiments. The representative data and plots of average end-pulse current in Figure 8 indicate the complete lack of any contribution of charybdotoxin-sensitive Kv channels to whole cell RPV KDR current.
|
| Discussion |
|---|
|
|
|---|
The view that vascular KDR are inhibited by 4-AP after transition to the open state is supported by the following: (1) the decline in KDR amplitude in 4-AP was pulse-dependent and prolonged by increasing the interpulse interval. The time-course of inhibition would not be expected to vary with interpulse interval if 4-AP blocked the channels in the closed state. (2) A stable level of inhibition of KDR current was not observed during depolarizing steps applied after prolonged treatment with 4-AP at -60 mV. If 4-AP could block the channels in the closed state, then an immediate stable level of inhibition would have been observed. (3) The initial activation of current during the first pulse after 5-minute 4-AP treatment at -60 mV was unchanged, but block by 4-AP developed during the pulse. An analysis of the pulse dependence and effect of interpulse interval on inhibition of smooth muscle KDR by 4-AP was not performed previously, but a decline in burst duration of KDR1 channels of colonic myocytes consistent with an open channel block mechanism was reported by Koh et al.25 Our observation of a decline in mean open time is also consistent with previous reports concerning 4-AP block of Kv1.2, Kv2.1, and Kv3.1.12,14 The conclusion that RPV KDR are affected by 4-AP after transition to the open state is different, however, from that in a previous study of rabbit coronary arterial KDR.21
That the inhibition by 4-AP of RPV KDR was associated with a positive shift in the voltage dependence of activation is consistent with previous reports for vascular KDR of other vessels.21,30,31 However, the shift in activation of coronary arterial KDR was attributed to unblock of channels inhibited by 4-AP while in the closed state.21 Based on the present data, however, this explanation does not appear to be appropriate. Our findings are not consistent with a closed-state block of vascular KDR, but they do indicate that the interaction with 4-AP is maintained following channel closure. This is suggested by the lack of relief of 4-AP block of KDR or Kv1.5 during prolonged washout at -60 mV. The voltage dependence of unblock was analyzed, but no difference in the time course of increase in current was apparent during pulses to 0 and +20 mV. This indicates that the dissociation of 4-AP was unaffected by voltage, similar to that reported for Kv2.1 and Kv3.112 and, therefore, that a voltage-dependent unblock cannot explain the shift in voltage dependence of activation. A recent modeling paper by Armstrong and Loboda32 suggests that the voltage-dependence of 4-AP action on K+ channels may be attributed to the ability of 4-AP to bias the drug bound-open state to a drug bound-closed state, and therefore, the channels occupied with 4-AP do not open as easily at negative (eg, -40 mV) compared with positive potentials (eg, +50 mV). Because 4-AP remains bound to the channels after repolarization, the level of current recorded during a series of steps to increasing potentials is determined by (1) the level of block during the previous step and (2) the ability of the channels to open during the subsequent depolarization. A declining level of inhibition occurs when sequential steps are applied to increasingly depolarized potentials because the open state of the activation gate is favored more strongly with depolarization positive to -40 mV. The amplitude of tail currents recorded on repolarization will be affected in parallel leading to a shift in activation.
The findings of this study provide evidence of a heteromultimeric association of Kv1.2 and Kv1.5 in vascular KDR. The molecular identity of vascular KDR is not known for certain: the expression of subunits from several Kv families, including Kv1, Kv2, Kv3, Kv4, and Kv9, as well as Kvß subunits has been reported.58 For example, we identified the presence of Kv1.5 in RPV,8 and have subsequently identified the expression of Kv1.2 and Kv1.4, as well as Kvß1.1, Kvß1.2, Kvß1.3, Kvß2.1, and Kvß2.2 in Thorneloe et al.9 However, data which correlate the presence of individual Kv subunits with specific biophysical, pharmacological, and/or functional properties of vascular KDR are limited.8,29,3335 This study shows that RPV KDR exhibit a shift in voltage dependence of activation due to 4-AP, as well as a lack of sensitivity to charybdotoxin. Kv1.5 channels are not affected by charybdotoxin,28,29 but we found that RPV Kv1.5 did not exhibit the shift in activation displayed by the native channels when expressed alone or in the presence of Kvß2.1 subunit in L cells. In contrast, block by 4-AP of Kv1.2 channels displayed a positive shift in activation in the presence of 4-AP, but Kv1.2 channels are sensitive to charybdotoxin.2729 These data indicate, therefore, that the properties of RPV KDR cannot be mimicked by homotetrameric Kv1.5 or Kv1.2 channels. Significantly, however, the shift in activation in 4-AP was apparent when RPV Kv1.2 and Kv1.5 were coexpressed or expressed as a tandem construct to yield heteromultimeric channels, which are known to be unaffected by charybdotoxin.29 Thus, channels due to the heteromultimeric association of Kv1.2 and Kv1.5, but not homotetramers of these subunits, possess pharmacological identity with vascular KDR in terms of their characteristics of 4-AP block and lack of sensitivity to charybdotoxin. Direct evidence that Kv1.2 and Kv1.5 associate to form heteromultimeric Kv channels in RPV was obtained in coimmunoprecipitation experiments using subunit-specific antibodies, as reported in the preceding paper.9 The presence of a band of appropriate molecular weight for Kv1.5 was identified in immunoblots of RPV protein immunoprecipitated using a Kv1.2 antibody.9 This finding provides direct evidence that Kv1.2 and Kv1.5 coassemble in RPV, but in isolation, the data do not provide any indication concerning the relative importance of this association to KDR channel formation and whole-cell KDR current. The pharmacological data obtained in this study indicate that heteromultimeric Kv1.2-Kv1.5 channels are the dominant channel complex and that there is a minimal/no contribution of homomultimers of Kv1.2 or Kv1.5 in RPV myocytes.
In summary, the findings of this study indicate that 4-AP inhibits native vascular KDR channels via an open-state blocking mechanism that is associated with a shift in voltage dependence of activation. The heteromultimeric interaction of Kv1.2 and Kv1.5 provides a molecular explanation for this shift in activation due to 4-AP and lack of sensitivity of the native channels to charybdotoxin. This feature of 4-AP inhibition is a characteristic that can be exploited as a tool in the determination of subunit composition of vascular KDR of different vessels (eg, coronary artery5 and pulmonary artery7), as well as cardiac myocytes,5 which are also known to express Kv1.2 and Kv1.5.
| Acknowledgments |
|---|
Received March 9, 2001; revision received October 8, 2001; accepted October 16, 2001.
| References |
|---|
|
|
|---|
2. Leblanc N, Wan X, Leung PM. Physiological role of Ca2+-activated and voltage-dependent K+ currents in rabbit coronary myocytes. Am J Physiol.. 1994; 266: C1523C1537.
3. Knot HJ, Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol.. 1995; 269: H384H355.
4. Dong H, Waldron GJ, Cole WC, Triggle CR. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery. Br J Pharmacol.. 1998; 123: 821832.
5. Roberds SL, Tamkun MM. Cloning and tissue-specific expression of five voltage-gated potassium channel cDNAs expressed in rat heart. Proc Natl Acad Sci U S A. 1991; 88: 17891802.
6. Overturf KE, Russell SN, Carl A, Vogalis F, Hart PJ, Hume JR, Sanders KM, Horowitz B. Cloning and characterization of a Kv1.5 delayed rectifier K+ channel from vascular and visceral smooth muscles. Am J Physiol.. 1994; 267: C1231C1238.
7. Yuan X-J, Wang J, Juhaszova M, Golovina VA, Rubin LJ. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol.. 1998; 274: L621L635.
8. Clément-Chomienne O, Ishii K, Walsh MP, Cole WC. Identification, cloning and expression of rabbit smooth muscle Kv1.5 and comparison with native delayed rectifier K+ current. J Physiol.. 1999; 515: 653667.
9. Thorneloe LS, Chen TT, Kerr PM, Grier EF, Horowitz B, Cole WC, Walsh MP. Molecular composition of 4-aminopyridine-sensitive voltage-gated K+ channels of vascular smooth muscle. Circ Res.. 2001; 89: 10301037.
10. Kirsch GE, Narahashi T. Site of action and active form of aminopyridines in squid axon membranes. J Pharmacol Exp Ther.. 1983; 226: 174179.
11. Choquet D, Korn H. Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes. J Gen Physiol.. 1992; 99: 217240.
12. Kirsch GE, Drewe JA. Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels. J Gen Physiol.. 1993; 102: 797816.
13. Kehl SJ. 4-Aminopyridine causes a voltage-dependent block of the transient outward K+ current in rat melanotrophs. J Physiol.. 1990; 431: 515528.
14. Russell SN, Publicover NG, Hart PJ, Carl A, Hume JR, Sanders KM, Horowitz B. Block by 4-aminopyridine of a Kv1.2 delayed rectifier K+ current expressed in Xenopus oocytes. J Physiol.. 1994; 481: 571584.
15. Tseng G-N, Jiang M, Yao J-A. Reverse use-dependence of Kv4.2 blockade by 4-aminopyridine. J Pharmacol Exp Ther.. 1996; 279: 865876.
16. Tseng G-N. Different state dependences of 4-aminopyridine binding to rKv1.4 and rKv4.2: role of the cytoplasmic halves of the fifth and sixth transmembrane segments. J Pharmacol Exp Ther.. 1999; 290: 569577.
17. Stephens GJ, Garratt JC, Robertson B, Owen DG. On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1. J Physiol.. 1994; 477: 187196.
18. Yamane T, Furukawa T, Hiraoka M. 4-Aminopyridine block of the noninactivating cloned K+ channel Kv1.5 expressed in Xenopus oocytes. Am J Physiol.. 1995; 269: H556H564.
19. Fedida D, Bouchard R, Closed-, and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5. J Pharmacol Exp Ther.. 1995; 275: 864876.
20. Fedida D, Bouchard R, Chen FSP. Slow gating charge immobilization in the human potassium channel Kv1.5 and its prevention by 4-aminopyridine. J Physiol.. 1996; 494: 377387.
21. Remillard C, Leblanc N. Mechanism of inhibition of delayed rectifier K+ current by 4-aminopyridine in rabbit coronary myocytes. J Physiol.. 1996; 491: 383400.
22. Aiello EA, Walsh MP, Cole WC. Phosphorylation by protein kinase A enhances delayed rectifier K+ current in rabbit vascular smooth muscle cells. Am J Physiol.. 1995; 268: H926H934.
23. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FS. Improved patch clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch.. 1981; 391: 85100.
24. Aiello EA, Malcolm AT, Walsh MP, Cole WC. ß-Adrenoceptor activation and protein kinase A regulate delayed rectifier K+ channels of vascular smooth muscle cells. Am J Physiol.. 1998; 275: H448H459.
25. Koh SD, Sanders KM, Carl A. Regulation of smooth muscle delayed rectifier K+ channels by protein kinase A. Pflügers Arch.. 1996; 432: 401412.
26. Uebele VN, England SK, Chaudhary A, Tamkun MM, Snyders DJ. Functional differences in Kv1.5 properties expressed in mammalian cell lines are due to the presence of endogenous Kvß2.1 subunits. J Biol Chem.. 1996; 271: 24062412.
27. Stuhmer W, Stocker M, Sakmann P, Seeburg A, Baumann A, Grupe A, Pongs O. Potassium channels expressed from rat brain cDNA have delayed rectifier properties. FEBS Lett.. 1988; 242: 199206.
28. Grissmer S, Niguyen AN, Aiyar J, Hanson DJ, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol.. 1994; 45: 12271234.
29. Russell SN, Overturf KE, Horowitz B. Heteromultimeric formation and charybdotoxin sensitivity of two K+ channels cloned from smooth muscle. Am J Physiol.. 1994; 267: C1729C1733.
30. Okabe K, Kitamura K, Kuriyama H. Features of 4-aminopyridine sensitive outward current observed in single smooth muscle cells from the rabbit pulmonary artery. Pflügers Arch.. 1987; 409: 561568.
31. Volk KA, Matsuda JJ, Shibata EF. A voltage-dependent potassium current in rabbit coronary artery smooth muscle cells. J Physiol.. 1991; 439: 751768.
32. Armstrong CM, Loboda A. A model for 4-aminopyridine action on K channels: similarities to tetraethylammonium ion action. Biophys J.. 2001; 81: 895904.
33. Hulme JT, Coppock EA, Felipe A, Martens JR, Tamkun MM. Oxygen sensitivity of cloned voltage-gated K+ channels expressed in the pulmonary vasculature. Circ Res.. 1999; 85: 489497.
34. Patel AJ, Lazdunski M, Honoré E. Kv2.1/Kv9.3, a novel ATP-dependent delayed rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J.. 1997; 16: 61156625.
35. Osipenko ON, Tate RJ, Gurney AM. Potential role for Kv3.1b channels as oxygen sensors. Circ Res.. 2000; 86: 534540.
This article has been cited by other articles:
![]() |
A. K. Dua, N. Dua, and C. L. Murrant Skeletal muscle contraction-induced vasodilator complement production is dependent on stimulus and contraction frequency Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H433 - H442. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Johnson, A. F. El-Yazbi, M. F. Hughes, D. C. Schriemer, E. J. Walsh, M. P. Walsh, and W. C. Cole Identification and Functional Characterization of Protein Kinase A-catalyzed Phosphorylation of Potassium Channel Kv1.2 at Serine 449 J. Biol. Chem., June 12, 2009; 284(24): 16562 - 16574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Straub, H. Girouard, P. E. Doetsch, R. M. Hannah, M. K. Wilkerson, and M. T. Nelson Regulation of intracerebral arteriolar tone by Kv channels: effects of glucose and PKC Am J Physiol Cell Physiol, January 1, 2009; 297(3): C788 - C796. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Telezhkin, T. Goecks, A. D. Bonev, G. Osol, and N. I. Gokina Decreased function of voltage-gated potassium channels contributes to augmented myogenic tone of uterine arteries in late pregnancy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H272 - H284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Armstrong, A. K. Dua, and C. L. Murrant Potassium initiates vasodilatation induced by a single skeletal muscle contraction in hamster cremaster muscle J. Physiol., June 1, 2007; 581(2): 841 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Remillard, D. D. Tigno, O. Platoshyn, E. D. Burg, E. E. Brevnova, D. Conger, A. Nicholson, B. K. Rana, R. N. Channick, L. J. Rubin, et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1837 - C1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gautier, J.-M. Hyvelin, V. de Crescenzo, V. Eder, and P. Bonnet Heterogeneous Kv1 function and expression in coronary myocytes from right and left ventricles in rats Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H475 - H482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishiguro, A. D. Morielli, K. Zvarova, B. I. Tranmer, P. L. Penar, and G. C. Wellman Oxyhemoglobin-Induced Suppression of Voltage-Dependent K+ Channels in Cerebral Arteries by Enhanced Tyrosine Kinase Activity Circ. Res., November 24, 2006; 99(11): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rogers, G. M. Dick, J. D. Knudson, M. Focardi, I. N. Bratz, A. N. Swafford Jr., S.-i. Saitoh, J. D. Tune, and W. M. Chilian H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2473 - H2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Gittelman and B. L Tempel Kv1.1-Containing Channels Are Critical for Temporal Precision During Spike Initiation J Neurophysiol, September 1, 2006; 96(3): 1203 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Straub and M. T. Nelson Molecular Coding of Kv1 Channels to Oppose Myogenic Constriction Circ. Res., July 7, 2006; 99(1): 13 - 14. [Full Text] [PDF] |
||||
![]() |
O. Platoshyn, E. E. Brevnova, E. D. Burg, Y. Yu, C. V. Remillard, and J. X.-J. Yuan Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C907 - C916. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, D. R. Hansen, I. Kim, and T. A. Gilbertson Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds Am J Physiol Cell Physiol, October 1, 2005; 289(4): C868 - C880. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Bratz, G. M. Dick, L. D. Partridge, and N. L. Kanagy Reduced molecular expression of K+ channel proteins in vascular smooth muscle from rats made hypertensive with N{omega}-nitro-L-arginine Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1277 - H1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Plane, R. Johnson, P. Kerr, W. Wiehler, K. Thorneloe, K. Ishii, T. Chen, and W. Cole Heteromultimeric Kv1 Channels Contribute to Myogenic Control of Arterial Diameter Circ. Res., February 4, 2005; 96(2): 216 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nesti, B. Everill, and A. D. Morielli Endocytosis as a Mechanism for Tyrosine Kinase-dependent Suppression of a Voltage-gated Potassium Channel Mol. Biol. Cell, September 1, 2004; 15(9): 4073 - 4088. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dang, K. Bielefeldt, and G. F. Gebhart Gastric ulcers reduce A-type potassium currents in rat gastric sensory ganglion neurons Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G573 - G579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fountain, A. Cheong, R. Flemming, L. Mair, A. Sivaprasadarao, and D. J. Beech Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle J. Physiol., April 1, 2004; 556(1): 29 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Luykenaar, S. E. Brett, B. N. Wu, W. B. Wiehler, and D. G. Welsh Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1088 - H1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Albarwani, L. T Nemetz, J. A Madden, A. A Tobin, S. K England, P. F Pratt, and N. J Rusch Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels J. Physiol., September 15, 2003; 551(3): 751 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohya, G. P. Sergeant, I. A. Greenwood, and B. Horowitz Molecular Variants of KCNQ Channels Expressed in Murine Portal Vein Myocytes: A Role in Delayed Rectifier Current Circ. Res., May 16, 2003; 92(9): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S Thorneloe and M. T Nelson Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current J. Physiol., May 15, 2003; 549(1): 65 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M Brew, J. L Hallows, and B. L Tempel Hyperexcitability and reduced low threshold potassium currents in auditory neurons of mice lacking the channel subunit Kv1.1 J. Physiol., April 1, 2003; 548(1): 1 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M Fearon, R. J Thompson, I. Samjoo, C. Vollmer, L. C Doering, and C. A Nurse O2-sensitive K+ channels in immortalised rat chromaffin-cell-derived MAH cells J. Physiol., December 15, 2002; 545(3): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Allen, M. Iftinca, W. C Cole, and F. Plane Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions J. Physiol., December 15, 2002; 545(3): 975 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Thorneloe, T. T. Chen, P. M. Kerr, E. F. Grier, B. Horowitz, W. C. Cole, and M. P. Walsh Molecular Composition of 4-Aminopyridine-Sensitive Voltage-Gated K+ Channels of Vascular Smooth Muscle Circ. Res., November 23, 2001; 89(11): 1030 - 1037. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |